cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Angion Biomedica Corp
15 own
11 watching
Current Price
$0.98
$-0.01
(-1.01%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
29.51M
52-Week High
52-Week High
2.04
52-Week Low
52-Week Low
0.46
Average Volume
Average Volume
0.31M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization29.51M
icon52-Week High2.04
icon52-Week Low0.46
iconAverage Volume0.31M
iconDividend Yield--
iconP/E Ratio--
What does the Angion Biomedica Corp do?
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company s lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primarily in the kidney and lung. It also develops ANG-3777, a hepatocyte growth factor mimetic to treat acute organ injuries, such as delayed graft function; ROCK2 inhibitors programs for fibrotic diseases; and CYP11B2 inhibitor program. The company was incorporated in 1998 and is based in Uniondale, New York.
Read More
How much money does Angion Biomedica Corp make?
News & Events about Angion Biomedica Corp.
PR Newswire
1month ago
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO PR Newswire NEW YORK, April 17, 2023 NEW YORK, April 17, 2023 /PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating the...
Globe Newswire
1month ago
NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: (NASDAQ: FRBA)s merger with Malvern Bancorp, ...
PR Newswire
1month ago
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVA SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVA PR Newswire NEW YORK, April 11, 2023 NEW YORK, April 11, 2023 /PRNewswire/ --Halper Sadeh LLC, an investor rights law firm, is investigating the following...
PR Newswire
1month ago
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, ANGN, TIG SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MPB, ANGN, TIG PR Newswire NEW YORK, April 6, 2023 NEW YORK, April 6, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following...
Globe Newswire
2 months ago
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc. (NASDAQ: CSII)s ...
Frequently Asked Questions
Frequently Asked Questions
What is Angion Biomedica Corp share price today?
plus_minus_icon
Can Indians buy Angion Biomedica Corp shares?
plus_minus_icon
How can I buy Angion Biomedica Corp shares from India?
plus_minus_icon
Can Fractional shares of Angion Biomedica Corp be purchased?
plus_minus_icon
What are the documents required to start investing in Angion Biomedica Corp stocks?
plus_minus_icon
What is today’s traded volume of Angion Biomedica Corp?
plus_minus_icon
What is today’s market capitalisation of Angion Biomedica Corp?
plus_minus_icon
What is the 52-Week High and Low Range of Angion Biomedica Corp?
plus_minus_icon
What percentage is Angion Biomedica Corp down from its 52-Week High?
plus_minus_icon
What percentage is Angion Biomedica Corp up from its 52-Week Low?
plus_minus_icon
Current Price
$0.98
$-0.01
(-1.01%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00